In fibroblasts it upregulates IDH3α expression, partially reverting the CAF phenotype, and in carcinoma cells it decreases apoptosis and cell death, a hallmark of carcinoma cell aggressiveness. This evidence concerns the gene IDH3A and carcinoma.